DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

UBS Maintains Neutral on Qiagen, Lowers Price Target to $36

UBS maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $39 to $36.

Benzinga · 01/10/2020 15:43

UBS maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $39 to $36.